Literature DB >> 4045247

Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.

V G Hemming, G A Prince, R L Horswood, W J London, B R Murphy, E E Walsh, G W Fischer, L E Weisman, P A Baron, R M Chanock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4045247     DOI： 10.1093/infdis/152.5.1083

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  27 in total

Review 1.  Use of intravenous immunoglobulins for prophylaxis or treatment of infectious diseases.

Authors:  V G Hemming
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

Review 2.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

3.  Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.

Authors:  J L Muñoz; C A McCarthy; M E Clark; C B Hall
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Respiratory syncytial virus and the infant immune response.

Authors:  G L Toms; R Scott
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

5.  Resistance to human respiratory syncytial virus (RSV) infection induced by immunization of cotton rats with a recombinant vaccinia virus expressing the RSV G glycoprotein.

Authors:  N Elango; G A Prince; B R Murphy; S Venkatesan; R M Chanock; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 6.  Detection, pathogenesis, and therapy of respiratory syncytial virus infections.

Authors:  R C Welliver
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 7.  Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.

Authors:  V G Hemming; G A Prince; J R Groothuis; G R Siber
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

8.  Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats.

Authors:  G A Prince; V G Hemming; R L Horswood; P A Baron; R M Chanock
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

9.  Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin.

Authors:  H C Meissner; D R Fulton; J R Groothuis; R L Geggel; G R Marx; V G Hemming; T Hougen; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

10.  Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Authors:  R Weltzin; S A Hsu; E S Mittler; K Georgakopoulos; T P Monath
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.